Enterobacteriaceae Infection Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Enterobacteriaceae Infection Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enterobacteriaceae Infection Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enterobacteriaceae Infection Drug Overall Market Size
2.1 Global Enterobacteriaceae Infection Drug Market Size: 2022 VS 2030
2.2 Global Enterobacteriaceae Infection Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Enterobacteriaceae Infection Drug Players in Global Market
3.2 Top Global Enterobacteriaceae Infection Drug Companies Ranked by Revenue
3.3 Global Enterobacteriaceae Infection Drug Revenue by Companies
3.4 Top 3 and Top 5 Enterobacteriaceae Infection Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Enterobacteriaceae Infection Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Enterobacteriaceae Infection Drug Players in Global Market
3.6.1 List of Global Tier 1 Enterobacteriaceae Infection Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Enterobacteriaceae Infection Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Enterobacteriaceae Infection Drug Market Size Markets, 2022 & 2030
4.1.2 Beta-lactams Drugs
4.1.3 Carbapenems Drugs
4.1.4 Fluoroquinolones Drugs
4.1.5 Others
4.2 By Type - Global Enterobacteriaceae Infection Drug Revenue & Forecasts
4.2.1 By Type - Global Enterobacteriaceae Infection Drug Revenue, 2018-2023
4.2.2 By Type - Global Enterobacteriaceae Infection Drug Revenue, 2024-2030
4.2.3 By Type - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Enterobacteriaceae Infection Drug Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Enterobacteriaceae Infection Drug Revenue & Forecasts
5.2.1 By Application - Global Enterobacteriaceae Infection Drug Revenue, 2018-2023
5.2.2 By Application - Global Enterobacteriaceae Infection Drug Revenue, 2024-2030
5.2.3 By Application - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Enterobacteriaceae Infection Drug Market Size, 2022 & 2030
6.2 By Region - Global Enterobacteriaceae Infection Drug Revenue & Forecasts
6.2.1 By Region - Global Enterobacteriaceae Infection Drug Revenue, 2018-2023
6.2.2 By Region - Global Enterobacteriaceae Infection Drug Revenue, 2024-2030
6.2.3 By Region - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Enterobacteriaceae Infection Drug Revenue, 2018-2030
6.3.2 US Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.3.3 Canada Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.3.4 Mexico Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Enterobacteriaceae Infection Drug Revenue, 2018-2030
6.4.2 Germany Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.4.3 France Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.4.4 U.K. Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.4.5 Italy Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.4.6 Russia Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.4.7 Nordic Countries Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.4.8 Benelux Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Enterobacteriaceae Infection Drug Revenue, 2018-2030
6.5.2 China Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.5.3 Japan Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.5.4 South Korea Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.5.5 Southeast Asia Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.5.6 India Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Enterobacteriaceae Infection Drug Revenue, 2018-2030
6.6.2 Brazil Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.6.3 Argentina Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Enterobacteriaceae Infection Drug Revenue, 2018-2030
6.7.2 Turkey Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.7.3 Israel Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Enterobacteriaceae Infection Drug Market Size, 2018-2030
6.7.5 UAE Enterobacteriaceae Infection Drug Market Size, 2018-2030
7 Enterobacteriaceae Infection Drug Companies Profiles
7.1 Genentech
7.1.1 Genentech Company Summary
7.1.2 Genentech Business Overview
7.1.3 Genentech Enterobacteriaceae Infection Drug Major Product Offerings
7.1.4 Genentech Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.1.5 Genentech Key News & Latest Developments
7.2 Nanotherapeutics
7.2.1 Nanotherapeutics Company Summary
7.2.2 Nanotherapeutics Business Overview
7.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Major Product Offerings
7.2.4 Nanotherapeutics Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.2.5 Nanotherapeutics Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Enterobacteriaceae Infection Drug Major Product Offerings
7.3.4 Novartis Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Enterobacteriaceae Infection Drug Major Product Offerings
7.4.4 Pfizer Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Nymox Pharmaceutical
7.5.1 Nymox Pharmaceutical Company Summary
7.5.2 Nymox Pharmaceutical Business Overview
7.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Major Product Offerings
7.5.4 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.5.5 Nymox Pharmaceutical Key News & Latest Developments
7.6 Sequoia Sciences
7.6.1 Sequoia Sciences Company Summary
7.6.2 Sequoia Sciences Business Overview
7.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Major Product Offerings
7.6.4 Sequoia Sciences Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.6.5 Sequoia Sciences Key News & Latest Developments
7.7 Phico Therapeutics
7.7.1 Phico Therapeutics Company Summary
7.7.2 Phico Therapeutics Business Overview
7.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Major Product Offerings
7.7.4 Phico Therapeutics Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.7.5 Phico Therapeutics Key News & Latest Developments
7.8 Cantab Biopharmaceuticals
7.8.1 Cantab Biopharmaceuticals Company Summary
7.8.2 Cantab Biopharmaceuticals Business Overview
7.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Major Product Offerings
7.8.4 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue in Global Market (2018-2023)
7.8.5 Cantab Biopharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Enterobacteriaceae Infection Drug Market Opportunities & Trends in Global Market
Table 2. Enterobacteriaceae Infection Drug Market Drivers in Global Market
Table 3. Enterobacteriaceae Infection Drug Market Restraints in Global Market
Table 4. Key Players of Enterobacteriaceae Infection Drug in Global Market
Table 5. Top Enterobacteriaceae Infection Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Enterobacteriaceae Infection Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Enterobacteriaceae Infection Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Enterobacteriaceae Infection Drug Product Type
Table 9. List of Global Tier 1 Enterobacteriaceae Infection Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Enterobacteriaceae Infection Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Enterobacteriaceae Infection Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Enterobacteriaceae Infection Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Enterobacteriaceae Infection Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Enterobacteriaceae Infection Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Enterobacteriaceae Infection Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Enterobacteriaceae Infection Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2024-2030
Table 30. Genentech Company Summary
Table 31. Genentech Enterobacteriaceae Infection Drug Product Offerings
Table 32. Genentech Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Genentech Key News & Latest Developments
Table 34. Nanotherapeutics Company Summary
Table 35. Nanotherapeutics Enterobacteriaceae Infection Drug Product Offerings
Table 36. Nanotherapeutics Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Nanotherapeutics Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Enterobacteriaceae Infection Drug Product Offerings
Table 40. Novartis Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Enterobacteriaceae Infection Drug Product Offerings
Table 44. Pfizer Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Nymox Pharmaceutical Company Summary
Table 47. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product Offerings
Table 48. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Nymox Pharmaceutical Key News & Latest Developments
Table 50. Sequoia Sciences Company Summary
Table 51. Sequoia Sciences Enterobacteriaceae Infection Drug Product Offerings
Table 52. Sequoia Sciences Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Sequoia Sciences Key News & Latest Developments
Table 54. Phico Therapeutics Company Summary
Table 55. Phico Therapeutics Enterobacteriaceae Infection Drug Product Offerings
Table 56. Phico Therapeutics Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Phico Therapeutics Key News & Latest Developments
Table 58. Cantab Biopharmaceuticals Company Summary
Table 59. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product Offerings
Table 60. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Cantab Biopharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Enterobacteriaceae Infection Drug Segment by Type in 2022
Figure 2. Enterobacteriaceae Infection Drug Segment by Application in 2022
Figure 3. Global Enterobacteriaceae Infection Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Enterobacteriaceae Infection Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Enterobacteriaceae Infection Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Enterobacteriaceae Infection Drug Revenue in 2022
Figure 8. By Type - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 16. US Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 20. Germany Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 28. China Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Enterobacteriaceae Infection Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Enterobacteriaceae Infection Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Genentech Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Nanotherapeutics Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sequoia Sciences Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Phico Therapeutics Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
